Investigator Support Services
1320 N. Milwaukee Ave.
Chicago, Illinois 60622
773-278-1567 http://www.researchsite.net/investigators karen@researchsite.net

Use our guide to learn which trials are right for you!

Investigator Support Services (ISS) eliminates the challenges and costs associated with identifying high-quality investigators for phase I-IV clinical trials. With more than 15 years of unrivaled experience, ISS brings quality and efficiency to site selection within every therapeutic area. We deliver exceptional client service by matching the most appropriate investigators to the complex needs of pharmaceutical sponsors and contract research organizations (CROs). Upcoming drug development projects benefit from:

  • Large network of phase I-IV research facilities
  • Investigators matched to sponsor needs
  • Rapid referral of pre-qualified investigators
  • Sponsor negotiates directly with site personnel
  • No obligation - sponsor/CRO makes the final selection decision
  • No fee for sponsors/CROs

With over 2,500 investigators, board certified in all major medical specialties, our research facilities have the experienced personnel, patient populations, and capabilities necessary for phase I-IV drug and device study participation.

  • ISS places investigators in more than 140 clinical trials annually
  • We pre-qualify and submit, on average, 4.25 investigators per protocol
  • On average, 57% of submitted investigators are selected for participation,/li>

With an average of 9 years in clinical research and 26 drug and device studies conducted, our Board Certified investigators have prior experience in virtually every therapeutic area, including:

  • Addiction Medicine
  • Allergy and Immunology
  • Anesthesiology
  • Cardiovascular Disease
  • Child and Adolescent Psychiatry
  • Clinical Neurophysiology
  • Colon and Rectal Surgery
  • Critical Care Medicine
  • Dental
  • Dermatology
  • Electrodiagnostic Medicine
  • Emergency Medicine
  • Endocrinology
  • Family Practice
  • Gastroenterology
  • Geriatric Medicine
  • Gynecologic Oncology
  • Hand Surgery
  • Hematology
  • Infectious Disease
  • Internal Medicine
  • Interventional Cardiology
  • Neonatal–Perinatal Medicine
  • Nephrology
  • Neurology
  • Neuro-Rehabilitation
  • Obstetrics and Gynecology
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology
  • Pain Medicine
  • Pediatrics
  • Pharmacology/ Toxicology
  • Physical Medicine and Rehabilitation
  • Plastic Surgery
  • Podiatry
  • Preventive Medicine
  • Psychiatry
  • Pulmonary Diseases
  • Radiology
  • Reproductive Endocrinology
  • Rheumatology
  • Sleep Medicine
  • Sports Medicine
  • Surgery
  • Thoracic Surgery
  • Urogynecology
  • Urology
  • Vascular and Interventional Radiology
  • Vascular Surgery

Clinical Research Coordinators
Coordinators are fully trained according to ICH-GCP guidelines and our research facilities average 3 coordinators each, to efficiently conduct multiple studies. More than 50% of our facilities employ ACRP-certified coordinators (CCRC) and nearly 65% have nurse coordinators.

Support Staff
Supporting our investigators and coordinators in their study-related activities, our sites employ a blend of additional support personnel, including:

  • Administrative support staff at 62% of our facilities
  • Regulatory support staff at 51% of our facilities
  • Patient Recruitment support staff at 45% of our facilities

Patient Population
Average percentage of patient population among our US research facilities, broken down by:
Age -

  • Age 0 to 2 years: 2%
  • Age 2 to 11 years: 6%
  • Age 12 to 18 years: 9%
  • Age 65 years or older: 29%

Race and Ethnicity -

  • Caucasian: 60%
  • African-American/Black: 18%
  • Hispanic: 13%
  • Asian/Pacific Islander: 4%
  • Native American: 1%
  • Other/Not categorized: 4%

Gender -

  • Male: 45%
  • Female: 55%

Patient Recruitment
To meet inpatient and outpatient recruitment goals, many of our locations offer dedicated recruitment personnel experienced in a variety of localized recruitment services. To ensure successful patient recruitment in your studies, we monitor historical site performance and track actual enrollment for each study. Substantial patient access is also demonstrated through:

  • Large patient databases
  • Community outreach
  • Ad placement experience
  • Physician referral relationships

Cardiology/Vascular Diseases
Dental/Maxillofacial Surgery
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Hematology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Oncology
Ophthalmology
Otolaryngology
Pediatrics/Neonatology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Trauma/Emergency Medicine

US Facilities
ISS has long-term relationships with over 1200 experienced investigators in nearly every region of the United States. With facilities in urban centers as well as suburban and rural areas, our sites provide large, diverse patient populations for your disease and device studies. Research studies are conducted in a variety of medical settings, including: private practices, clinics, full-time research sites, and community hospitals. Our inpatient and outpatient facilities offer:

  • High-speed Internet access
  • Electronic data capture (EDC) experience
  • Ability to work with Central IRBs
  • Rapid budget and contract negotiations

Phase One Units
Averaging 35 completed studies and seven years in clinical research, our early phase investigators are experienced working with Healthy Normals and disease populations in several specialty areas. Dedicated nurse coordinators, pharmacists, and lab technicians provide study support and around-the-clock patient care. Our Phase One Units average 4,700 square feet and 5-52 beds. Many also include:

  • 24-hour laboratories and pharmacies
  • Private/semi-private dormitories with showers
  • Indoor/outdoor recreation areas and group activities
  • Kitchens and study rooms,/li>

Rest of World
ISS offers access to an elite group of investigators throughout Canada, India, and Mexico. All research facilities include ICH-GCP trained investigators and coordinators with prior phase I-IV trial experience in virtually all medical specialties. Facilities outside of the US offer additional services, including:

  • Full-time coordinators trained in FDA and local regulatory requirements
  • IRB submission and approval with rapid turn-around
  • Collection and management of paper and electronic study documents
  • Local curriers and Customs support for rapid drug import and delivery
  • Secure, on-site pharmacies and laboratories
  • Multilingual personnel and certified translation departments
  • Substantial access to eligible patients and treatment naïve populations

Karen Bork
Investigator Support Services
1320 N. Milwaukee Ave.
Chicago, IL 60642
USA
773.278.1567
773.278.2935 (fax)
bork.karen@researchsite.net
www.researchsite.net/investigators


We've found
0 trials
at this facility